Pegcetacoplan for 52 Weeks Maintains Proteinuria Reduction and eGFR Stabilization for Pediatric Patients: Phase 3 VALIANT Subgroup Analysis

Jean E. Robillard MD, Professor of Pediatric Nephrology Director, Division of Pediatric Nephrology – Stead Family Children’s Hospital Associate Director, Molecular Otolaryngology and Renal Research Laboratory
University of Iowa Stead Family Children's Hospital
Iowa City, Iowa, United States